Results 271 to 280 of about 179,739 (339)

Balloon‐Expandable Versus Self‐Expanding Valves in Bicuspid Aortic Stenosis: Insights From the SWEDEHEART Registry

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Transcatheter aortic valve replacement (TAVR) is increasingly used in patients with bicuspid aortic valve (BAV) stenosis, but there is limited comparative data on balloon‐expandable (BEV) versus self‐expanding valves (SEV) in this population. Aim To compare clinical and hemodynamic outcomes between BEVs and SEVs in patients with BAV
Antros Louca   +13 more
wiley   +1 more source

Impact of Heart Failure and Chronic Kidney Disease on All‐Cause Mortality in Patients Undergoing Coronary Angiography: Results From the Finnish Kardio Multicentre Registry

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Heart failure (HF) and chronic kidney disease (CKD) are common comorbidities among patients undergoing coronary angiography. Both conditions are associated with increased risk of adverse cardiovascular outcomes and mortality. However, the joint prognostic impact of HF and CKD in this patient population remains unclear. Aims We aimed
Jari A. Laukkanen   +7 more
wiley   +1 more source

Feasibility and Safety of Transfemoral Aortic Valve Replacement Using Local Anesthesia in the Catheterization Suite Versus General Anesthesia in the Operation Theater

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background For over a decade, transfemoral transcatheter aortic valve replacements (TF‐TAVR) have been performed at the University Hospital of Nancy. A minimalistic approach to TF‐TAVR, conducted without general anesthesia and entirely percutaneously in a catheterization suite (simplified approach), has been reported to be as safe and ...
Guillaume Abadié   +8 more
wiley   +1 more source

Prognostic Significance of Left Ventricular Mass Index and Renal Function Decline Rate in Chronic Kidney Disease G3 and G4

open access: gold, 2017
Jiun‐Chi Huang   +7 more
openalex   +1 more source

Three‐Cusp View Orientation in TAVI: Evaluating LOA Versus Non‐LOA Impact on Outcomes With Contemporary Valve Prostheses

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Optimal projection views during transcatheter aortic valve implantation (TAVI) procedures are critical for procedural success and patient outcomes. Aims This study investigated the influence of 3‐cusp view orientation—line of alignment (LOA) versus non‐LOA—on procedural outcomes in patients undergoing TAVI with contemporary ...
Rim Kasem Ali Sliman   +5 more
wiley   +1 more source

Treatment of Coronary Bifurcation Stenoses Using the DK Mini Crush Technique—Analysis of Resources and Technical Success

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background The DK‐mini‐Crush (DKMC) technique, an established strategy to treat coronary bifurcation stenoses, is known to be complex, with possible strain on time and resources. Aims To analyze predictors of technical failure as well as time and resourced required for each procedural step of th DKMC technique.
Florian Weidinger   +7 more
wiley   +1 more source

Drug‐Coated Balloon‐Based Versus Drug‐Eluting Stent‐Only Treatment for Large Vessel Coronary Artery Disease

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background Drug‐coated balloon (DCB) treatment has shown outcomes comparable to drug‐eluting stent (DES) in small vessel coronary disease. However, evidence for its application in large vessel coronary artery disease (CAD) remains limited. Aims This study evaluated the clinical impact of DCB‐based percutaneous coronary intervention (PCI) in ...
Eun‐Seok Shin   +5 more
wiley   +1 more source

Site‐Specific Antithrombotic Therapy: 24‐Month Outcomes of the Randomized DESyne BDS Plus Trial Using a Novel Triple‐Drug Eluting Coronary Implant With Two Anticoagulants and Sirolimus

open access: yesCatheterization and Cardiovascular Interventions, EarlyView.
ABSTRACT Background DESyne BDS Plus represents a novel triple drug therapy (TRx) applied on a coronary stent platform eluting the antiproliferative drug Sirolimus along with two anticoagulants (Rivaroxaban and Argatroban) to reduce the site‐specific thrombotic risk.
Stefan Verheye   +19 more
wiley   +1 more source

Home - About - Disclaimer - Privacy